These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34322473)

  • 1. Cost-Effectiveness Analysis of High-Risk Groups Tuberculosis Screening in Malaysia.
    Mohd Hassan NZA; Razali A; Shahari MR; Mohd Nor Sham Kunusagaran MSJ; Halili J; Zaimi NA; Bahari MS; Aminuddin F
    Front Public Health; 2021; 9():699735. PubMed ID: 34322473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A symptomatic approach to tuberculosis screening for high-risk groups in Malaysia: Cost-effectiveness and budget impact analysis.
    Mohd Hassan NZA; Razali A; Mohd Nor Sham Kunusagaran MSJ; Aminuddin F
    J Clin Tuberc Other Mycobact Dis; 2022 Dec; 29():100334. PubMed ID: 36262308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
    PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of community active case finding and household contact investigation for tuberculosis case detection in urban Africa.
    Sekandi JN; Dobbin K; Oloya J; Okwera A; Whalen CC; Corso PS
    PLoS One; 2015; 10(2):e0117009. PubMed ID: 25658592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target prioritization and strategy selection for active case-finding of pulmonary tuberculosis: a tool to support country-level project planning.
    Nishikiori N; Van Weezenbeek C
    BMC Public Health; 2013 Feb; 13():97. PubMed ID: 23374118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries.
    Kowada A
    J Infect; 2014 Jan; 68(1):32-42. PubMed ID: 23973660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis active case finding in Cambodia: a pragmatic, cost-effectiveness comparison of three implementation models.
    James R; Khim K; Boudarene L; Yoong J; Phalla C; Saint S; Koeut P; Mao TE; Coker R; Khan MS
    BMC Infect Dis; 2017 Aug; 17(1):580. PubMed ID: 28830372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong.
    Wong NS; Chan KCW; Wong BCK; Leung CC; Chan WK; Lin AWC; Lui GCY; Mitchell KM; Lee SS
    JAMA Netw Open; 2019 Sep; 2(9):e1910960. PubMed ID: 31490541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
    Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
    BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of active tuberculosis case finding strategies for immigrants in South Korea: Epidemiology and cost-effectiveness analysis.
    Park S; Sung C; Choi H; Lee YW; Kang Y; Kim HJ; Kim HY; Oh IH; Lee SH
    PLoS One; 2023; 18(4):e0283414. PubMed ID: 37079530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.
    Perlman DC; Gourevitch MN; Trinh C; Salomon N; Horn L; Des Jarlais DC
    J Urban Health; 2001 Sep; 78(3):550-67. PubMed ID: 11564856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis.
    Macintyre CR; Plant AJ; Hendrie D
    Health Econ; 2000 Jul; 9(5):411-21. PubMed ID: 10903541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness Analysis.
    Zwerling AA; Sahu M; Ngwira LG; Khundi M; Harawa T; Corbett EL; Chaisson RE; Dowdy DW
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):83-90. PubMed ID: 26049281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness study of tuberculosis and latent tuberculosis infection screening in prisons in Japan.
    Kawatsu L; Uchimura K; Ohkado A
    Int J Tuberc Lung Dis; 2020 May; 24(5):506-511. PubMed ID: 32398200
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for pulmonary tuberculosis in high-risk groups of diabetic patients.
    Ji Y; Cao H; Liu Q; Li Z; Song H; Xu D; Tian D; Qiu B; Wang J
    Int J Infect Dis; 2020 Apr; 93():84-89. PubMed ID: 31978585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
    Yakhelef N; Audibert M; Ferlazzo G; Sitienei J; Wanjala S; Varaine F; Bonnet M; Huerga H
    PLoS One; 2020; 15(1):e0227138. PubMed ID: 31999746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
    Lee DJ; Kumarasamy N; Resch SC; Sivaramakrishnan GN; Mayer KH; Tripathy S; Paltiel AD; Freedberg KA; Reddy KP
    PLoS One; 2019; 14(7):e0218890. PubMed ID: 31265470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.